Literature DB >> 24247143

A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.

Danielle L Jessen1, David S Bradley, Matthew L Nilles.   

Abstract

Numerous Gram-negative pathogens rely upon type III secretion (T3S) systems to cause disease. Several small-molecule inhibitors of the type III secretion systems have been identified; however, few targets of these inhibitors have been elucidated. Here we report that 2,2'-thiobis-(4-methylphenol) (compound D), inhibits type III secretion in Yersinia pestis, Yersinia pseudotuberculosis, and Pseudomonas aeruginosa. YopD, a protein involved in the formation of the translocon and regulatory processes of the type III secretion system, appears to play a role in the inhibition of secretion by compound D. The use of compound D in T3S regulatory mutants demonstrated a difference in secretion inhibition in the presence and absence of calcium. Interestingly, compound D was effective only under conditions without calcium, indicating that a secretion-active needle structure may be necessary for compound D to inhibit secretion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247143      PMCID: PMC3910845          DOI: 10.1128/AAC.01170-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  50 in total

Review 1.  The type III secretion injectisome, a complex nanomachine for intracellular 'toxin' delivery.

Authors:  Guy R Cornelis
Journal:  Biol Chem       Date:  2010-07       Impact factor: 3.915

2.  Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis.

Authors:  Mohamad A Hamad; Matthew L Nilles
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

Review 3.  The type III secretion system tip complex and translocon.

Authors:  C A Mueller; P Broz; G R Cornelis
Journal:  Mol Microbiol       Date:  2008-04-08       Impact factor: 3.501

Review 4.  The Yersinia deadly kiss.

Authors:  G R Cornelis
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

5.  YopD and LcrH regulate expression of Yersinia enterocolitica YopQ by a posttranscriptional mechanism and bind to yopQ RNA.

Authors:  Deborah M Anderson; Kumaran S Ramamurthi; Christina Tam; Olaf Schneewind
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis.

Authors:  R D Perry; M L Pendrak; P Schuetze
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

8.  Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.

Authors:  Lynne K Garrity-Ryan; Oak K Kim; Joan-Miquel Balada-Llasat; Victoria J Bartlett; Atul K Verma; Michael L Fisher; Cynthia Castillo; Warangkhana Songsungthong; S Ken Tanaka; Stuart B Levy; Joan Mecsas; Michael N Alekshun
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

9.  Function and molecular architecture of the Yersinia injectisome tip complex.

Authors:  Petr Broz; Catherine A Mueller; Shirley A Müller; Ansgar Philippsen; Isabel Sorg; Andreas Engel; Guy R Cornelis
Journal:  Mol Microbiol       Date:  2007-09       Impact factor: 3.501

10.  Isolation of Salmonella mutants resistant to the inhibitory effect of Salicylidene acylhydrazides on flagella-mediated motility.

Authors:  Isabel Martinez-Argudo; Andreas K J Veenendaal; Xia Liu; A Dorothea Roehrich; Maria C Ronessen; Giulia Franzoni; Katerine N van Rietschoten; Yusuke V Morimoto; Yumiko Saijo-Hamano; Matthew B Avison; David J Studholme; Keiichi Namba; Tohru Minamino; Ariel J Blocker
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more
  14 in total

Review 1.  On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

Authors:  Bronwyn J E Lyons; Natalie C J Strynadka
Journal:  Medchemcomm       Date:  2019-06-20       Impact factor: 3.597

2.  Identification of phenolic compounds that suppress the virulence of Xanthomonas oryzae on rice via the type III secretion system.

Authors:  Susu Fan; Fang Tian; Jianyu Li; William Hutchins; Huamin Chen; Fenghuan Yang; Xiaochen Yuan; Zining Cui; Ching-Hong Yang; Chenyang He
Journal:  Mol Plant Pathol       Date:  2016-07-01       Impact factor: 5.663

3.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

4.  Chemical Targeting and Manipulation of Type III Secretion in the Phytopathogen Xanthomonas campestris for Control of Disease.

Authors:  Le Zhou; Cheng Wang; Guo-Hua Wang; Zai-Wa Wei; Qiu-Xia Fu; Xiao-Hong Hang; Mei Yang; Bo-Le Jiang; Ji-Liang Tang
Journal:  Appl Environ Microbiol       Date:  2020-01-21       Impact factor: 4.792

5.  Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.

Authors:  Joanna B Goldberg; Cristian V Crisan; Justin M Luu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 6.  Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target.

Authors:  Alyssa C Fasciano; Lamyaa Shaban; Joan Mecsas
Journal:  EcoSal Plus       Date:  2019-02

7.  Characterization of the Binding of Hydroxyindole, Indoleacetic acid, and Morpholinoaniline to the Salmonella Type III Secretion System Proteins SipD and SipB.

Authors:  Andrew C McShan; Asokan Anbanandam; Sikta Patnaik; Roberto N De Guzman
Journal:  ChemMedChem       Date:  2016-03-18       Impact factor: 3.466

8.  Developing Cyclic Peptomers as Broad-Spectrum Type III Secretion System Inhibitors in Gram-Negative Bacteria.

Authors:  Hanh N Lam; Tannia Lau; Adam Lentz; Jessica Sherry; Alejandro Cabrera-Cortez; Karen Hug; Annalyse Lalljie; Joanne Engel; R Scott Lokey; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.938

Review 9.  Environmental Regulation of Yersinia Pathophysiology.

Authors:  Shiyun Chen; Karl M Thompson; Matthew S Francis
Journal:  Front Cell Infect Microbiol       Date:  2016-03-02       Impact factor: 5.293

Review 10.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.